ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$26.42
+3.18%
Mkt Cap $4.51B
Analyst Ratings
Buy
13
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
Implied Upside
+29.9%
Consensus $34.33 vs current $26.42
NASDAQ·Healthcare·Biotechnology
$26.42
+3.18%
Mkt Cap $4.51B
Buy
13
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
+29.9%
Consensus $34.33 vs current $26.42